16.04.2013
- Actelion, Europe's largest biotech company, said it may return to profit growth sooner than expected after its first-quarter earnings more than doubled and sales of its mainstay...
19.04.2012
- Europe's largest biotech company Actelion said it expects results of a key late-stage trial on heart and lung disease drug macitentan in the next few weeks after a strong Swiss...
